| About | Agenda | Exhibits | Registration |
It is generally recognised that early diagnosis significantly improves cancer survival rates; advances in technology are leading to achieving that desirable outcome. The Cancer Diagnostic Technology Summit provides a platform for leading developers to showcase the current and future directions of technology in cancer diagnosis. The Conference will explore advances in a range of diagnostic methodologies, and concerns that very early diagnosis may lead to treatment of biologically insignificant cancers.
Register NowBlood biopsy
Biomarkers in breath, saliva and urine
Cell separation and DNA sequencing
AI in imaging and data mining
Companies with cancer diagnostic technology at any stage of development
Early stage companies developing innovative diagnostic technology
Academic and clinical research teams
Oral and Poster Abstracts - please specify which. Posters will have an opportuinity to give a short presentation
Send a brief abstract to cdt21@sensor100.com
Follow the Template Guidelines for inclusion in the Conference Book of Abstracts
Prof. H Thomas Aretz MD, Harvard Medical School and Partners International
Dr. Michael Brand, Sensor100
Dr. Kalypso Charalambous, Institute of Biomedical Engineering, Imperial College London
Dr. Sylvain Ladame, Department of Bioengineering, Imperial College London